V
The WPI and their XMRV "discovery" is not all that it seems to be. Please, dig a little deeper people...
Who holds the patent for the reagents used in WPI's initial XMRV study? Why have the reagents from the study not been shared with other researchers who are attempting to replicate the findings?
The announcement of XMRV discovery was very well choreographed. 10/08/09: Science XMRV publication; 10/29/09: Dr. Peterson CFSAC presentation; 11/05/09: WPI press release announcing that VIP Dx is offering a lab test for XMRV; Mid-November 2009: WPI changed their website to state that none of the 101 patient cohort were from Petersons bio bank, and that none of the 101 patients had cancer. At least 4 patients from the Science study had cancer, according to Petersons CFSAC presentation (WPI-1118, WPI-1125, WPI-1150, WPI-1199). How many other patients had cancer? WPI states: Blood samples from the WPI repository were chosen at random and there were no patients chosen with lymphoma or mention of lymphoma in this study. Another preliminary study was done at a later date that had nothing to do with the XMRV Science publication. (http://www.wpinstitute.org/research/research_biobank.html) If WPI isnt forthcoming about this, how reliable is the info about the patient cohort or any other details about the study?
Why didnt WPI disclose that Harvey Whittemore is the sole owner of VIP Dx, and has been since 2005? Why doesnt WPI disclose that Judy Mikovits is the Vice President of VIP Dx, or that Vincent Lombardi is the Treasurer of VIP Dx? Clearly this is a conflict of interest and unethical. All parties involved have a financial motivation, and this has been cleverly hidden from the patient community.
Fact: Harvey Whittemore owns 100% of VIP Dx, (also known as Redlabs USA), and was the company President until 12/29/09.
Fact: Judy Mikovits is the Vice President of VIP Dx.
Fact: Vincent Lombardi founded VIP Dx in 2004, and sold it to Harvey Whittemore in 2005. He remains the company Treasurer. (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=3HqeF%2fFCg2b8fQKoGUKjpg%3d%3d&nt7=0)
Why has WPI and the Whittemore family not been transparent about their financial interest in XMRV? All of Harveys cronies are officers of WPI, VIP Dx, XMRV Diagnostics, and XMRV Holding Corporation. WPI Vice President, Michael Hillerby, is one of Harvey Whittemores cronies and is Secretary and Treasurer of XMRV Holding Corporation (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Hq0jXLdsqHTjwzedr32I5w%3d%3d).
Fact: Harvey Whitemore founded XMRV Diagnostics, LLC on 7/03/08 (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=jpuvh8GU2C0X6t5ANvP6ZQ%3d%3d&nt7=0).
Fact: Harvey Whitemore founded XMRV Holding Corporation on 7/30/09 (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Hq0jXLdsqHTjwzedr32I5w%3d%3d&nt7=0).
Please people, do your homework. We have too much to lose
Who holds the patent for the reagents used in WPI's initial XMRV study? Why have the reagents from the study not been shared with other researchers who are attempting to replicate the findings?
The announcement of XMRV discovery was very well choreographed. 10/08/09: Science XMRV publication; 10/29/09: Dr. Peterson CFSAC presentation; 11/05/09: WPI press release announcing that VIP Dx is offering a lab test for XMRV; Mid-November 2009: WPI changed their website to state that none of the 101 patient cohort were from Petersons bio bank, and that none of the 101 patients had cancer. At least 4 patients from the Science study had cancer, according to Petersons CFSAC presentation (WPI-1118, WPI-1125, WPI-1150, WPI-1199). How many other patients had cancer? WPI states: Blood samples from the WPI repository were chosen at random and there were no patients chosen with lymphoma or mention of lymphoma in this study. Another preliminary study was done at a later date that had nothing to do with the XMRV Science publication. (http://www.wpinstitute.org/research/research_biobank.html) If WPI isnt forthcoming about this, how reliable is the info about the patient cohort or any other details about the study?
Why didnt WPI disclose that Harvey Whittemore is the sole owner of VIP Dx, and has been since 2005? Why doesnt WPI disclose that Judy Mikovits is the Vice President of VIP Dx, or that Vincent Lombardi is the Treasurer of VIP Dx? Clearly this is a conflict of interest and unethical. All parties involved have a financial motivation, and this has been cleverly hidden from the patient community.
Fact: Harvey Whittemore owns 100% of VIP Dx, (also known as Redlabs USA), and was the company President until 12/29/09.
Fact: Judy Mikovits is the Vice President of VIP Dx.
Fact: Vincent Lombardi founded VIP Dx in 2004, and sold it to Harvey Whittemore in 2005. He remains the company Treasurer. (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=3HqeF%2fFCg2b8fQKoGUKjpg%3d%3d&nt7=0)
Why has WPI and the Whittemore family not been transparent about their financial interest in XMRV? All of Harveys cronies are officers of WPI, VIP Dx, XMRV Diagnostics, and XMRV Holding Corporation. WPI Vice President, Michael Hillerby, is one of Harvey Whittemores cronies and is Secretary and Treasurer of XMRV Holding Corporation (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Hq0jXLdsqHTjwzedr32I5w%3d%3d).
Fact: Harvey Whitemore founded XMRV Diagnostics, LLC on 7/03/08 (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=jpuvh8GU2C0X6t5ANvP6ZQ%3d%3d&nt7=0).
Fact: Harvey Whitemore founded XMRV Holding Corporation on 7/30/09 (http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Hq0jXLdsqHTjwzedr32I5w%3d%3d&nt7=0).
Please people, do your homework. We have too much to lose